This site displays a prototype of a “Web 2.0” version of the daily
Federal Register. It is not an official legal edition of the Federal
Register, and does not replace the official print version or the official
electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status.
For complete information about, and access to, our official publications
and services, go to
About the Federal Register
on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of
establishing the XML-based Federal Register as an ACFR-sanctioned
publication in the future. While every effort has been made to ensure that
the material on FederalRegister.gov is accurately displayed, consistent with
the official SGML-based PDF version on govinfo.gov, those relying on it for
legal research should verify their results against an official edition of
the Federal Register. Until the ACFR grants it official status, the XML
rendition of the daily Federal Register on FederalRegister.gov does not
provide legal notice to the public or judicial notice to the courts.
Notice
Enter a search term or FR citation e.g.
88 FR 38230 FR 78782024-13208USDA09/05/24RULE0503-AA39SORN
Choosing an item from
full text search results
will bring you to those results. Pressing enter in the search box
will also bring you to search results.
Choosing an item from
suggestions
will bring you directly to the content.
This table of contents is a navigational tool, processed from the
headings within the legal text of Federal Register documents.
This repetition of headings to form internal navigation links
has no substantive legal effect.
Comments are no longer being accepted.
See DATES for details.
Regulations.gov Data
Enhanced Content - Regulations.gov Data
FederalRegister.gov retrieves relevant information about this document
from Regulations.gov to provide users with additional context. This
information is not part of the official Federal Register document.
Guidance on Meetings with Industry and Investigators on the Research and Development of Tobacco Products
Agency Information Collection Activities; Proposed Collection; Comment Request; Proposed Small Dispensers Assessment under the Drug Supply Chain Security Act
Agency Information Collection Activities; Proposed Collection; Comment Request; Substances Prohibited from Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed
Agency Information Collection Activities; Proposed Collection; Comment Request; Generic Clearance for Quick Turnaround Testing of Communication Effectiveness
Agency Information Collection Activities; Proposed Collection; Comment Request; Q-Submission and Early Payor Feedback Request Programs and Medical Device Development Tools
Agency Information Collection Activities; Proposed Collection; Comment Request; Testing Communications On Medical Devices and Radiation-Emitting Products
Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practices for Positron Emission Tomography Drugs
Agency Information Collection Activities; Proposed Collection; Comment Request; Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act
Agency Information Collection Activities; Proposed Collection; Comment Request; Patent Term Restoration; Due Diligence Petitions; Filing, Format, and Content of Petitions
Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice (CGMP): Manufacturing, Processing, Packing, and Holding of Drugs; GMP for Finished Pharmaceuticals (Including Active Pharmaceutical Ingredients) and the Advanced Manufacturing Technologies Designation Program
Document page views are updated periodically throughout the day and are
cumulative counts for this document. Counts are subject to sampling,
reprocessing and revision (up or down) throughout the day.
Page views
303
as of
09/13/2026 at 12:15 am EDT
Other Formats
Enhanced Content - Other Formats
This document is also available in the following formats:
This PDF is FR Doc. 2026-16716 as it appeared on Public Inspection on
08/14/2026 at 8:45 am.
It was viewed
32
times while on Public Inspection.
If you are using public inspection listings for legal research, you
should verify the contents of the documents against a final, official
edition of the Federal Register. Only official editions of the
Federal Register provide legal notice of publication to the public and judicial notice
to the courts under 44 U.S.C. 1503 & 1507.
Learn more here.
Published Document: 2026-16716 (91 FR 53268)
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Amber Barrett, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-8867,
PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at
https://www.reginfo.gov/public/do/PRAMain.
An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.
Table 1—List of Information Collections Approved By OMB
Title of collection
OMB control
number
Date approval
expires
Electronic Products Requirements
0910-0025
5/31/2029
Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution
0910-0045
5/31/2029
Investigational Device Exemptions
0910-0078
5/31/2029
Agreement for Shipments of Devices for Sterilization
0910-0131
6/30/2029
Current Good Manufacturing Practice (CGMP): Manufacturing, Processing, Packing, and Holding of Drugs; GMP for Finished Pharmaceuticals (Including API), and AMT Designation
0910-0139
7/31/2029
Patent Term Restoration, Due Diligence Petitions, Filing, Format, and Content of Petitions
0910-0233
7/31/2029
Export of Medical Devices; Foreign Letters of Approval
0910-0264
3/31/2029
Prescription Drug User Fee Program
0910-0297
1/31/2029
Mammography Standards Quality Act Requirements
0910-0309
5/31/2029
Medical Devices; Humanitarian Use Devices
0910-0332
6/30/2029
Substances Prohibited from Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed
0910-0339
5/31/2029
Food Safety, Health, and Diet Survey
0910-0345
3/31/2029
510(k) Third-Party Review Program
0910-0375
6/30/2029
Medical Device Reporting
0910-0437
2/28/2029
Postmarket Surveillance of Medical Devices
0910-0449
6/30/2029
( printed page 53269)
Guidance for Reagents for Detection of Specific Novel Influenza A Viruses
0910-0584
6/30/2029
Authorization of Medical Products for Use Emergencies
0910-0595
5/31/2029
Administrative Procedures for Clinical Laboratory Improvement Amendments of 1988 Categorization
0910-0607
6/30/2029
Electronic Submission of Medical Device Registration and Listing
0910-0625
4/30/2029
Tobacco Product Establishment Registration and Submission of Certain Health Information
0910-0650
4/30/2029
Tobacco Health Document Submission
0910-0654
4/30/2029
Current Good Manufacturing Practices for Positron Emission Tomography (PET) Drugs
0910-0667
6/30/2029
Testing Communications on Medical Devices and Radiation-Emitting Products
0910-0678
7/31/2029
Generic Drug User Fee Program
0910-0727
1/31/2029
Guidance on Meetings with Industry and Investigators on the Research and Development of Tobacco Products
0910-0731
4/30/2029
Center for Devices and Radiological Health Appeals Processes
0910-0738
6/30/2029
Q-Submission and Early Payor Feedback Request Programs and Medical Device Development Tools
0910-0756
5/31/2029
Animal Food and Egg Regulatory Program Standards
0910-0760
5/31/2029
Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act
0910-0800
5/31/2029
Medical Device Accessories
0910-0823
3/31/2029
Data To Support Social and Behavioral Research as Used by the Food and Drug Administration
0910-0847
5/31/2029
Generic Clearance for Quick Turnaround Testing of Communication Effectiveness
0910-0876
4/30/2029
Obtaining Information to Understand and Challenges and Opportunities Encountered by Compounding Outsourcing Facilities
0910-0883
3/31/2029
The Real Cost Monthly Implementation Assessment
0910-0935
3/31/2029
Emerging Drug Safety Technology Program
0910-0936
5/31/2029
Small Dispensers Assessment Under the Drug Supply Chain Security Act
0910-0937
6/30/2029
Grace R. Graham,
Deputy Commissioner for Policy, Legislation, and International Affairs.